Pioneering Proteomics for Predictive Organ Health

Vero uses proteomics and machine learning to measure the biological age of each organ from a single blood draw—so intervention can begin earlier and with greater precision.

You are only as young as your oldest organ

Different organs age at different rates. Knowing which ones are aging faster gives you an advantage to target lifestyle actions that can slow, or even reverse, organ aging. When one organ improves, the whole system strengthens.

Percentile 28th
Heart Aligned

The aging process is nonlinear

Girl smiling in front of some green trees

And not consistent across organs

Percentile 4th
Brain Resilient
Percentile 28th
Heart Aligned
Percentile 72nd
Immune Emerging
60 years old
01
Brain
4th
RESILIENT
02
Heart
28th
ALIGNED
03
Immune
72nd
EMERGING
01
Brain
4th
RESILIENT
02
Heart
28th
ALIGNED
03
Immune
72nd
EMERGING
Built on Rigorous Science

On a mission to end age-related chronic disease

Developed from Stanford University research involving 45,000+ individuals over 15 years, Vero measures thousands of proteins with organ-specific signatures in your blood to detect the earliest molecular signs of age-related change.

These protein patterns shift years before traditional clinical markers or imaging reveal abnormalities.

Explore our published research:

How Vero Works

The Vero Compass*

Integrates biological, clinical, and wearable data into one predictive platform that guides precise interventions and measures how each organ responds over time, creating a continuous feedback loop to extend healthspan.
*Vero Compass™ is currently under development and for research purposes only.
Lady lying amongst flowers with arms behind her head
1

Blood Collection

A simple blood draw captures thousands of circulating proteins with organ-specific signatures. 
2

Proteomic Analysis

11,000+ proteins with organ-specific signatures and machine learning identify patterns associated with organ-level aging.
3

Organ-Specific Insight

Results are reported as percentiles relative to age-matched peers, highlighting where aging may be progressing or slowing.
4

Organ-Specific Intervention

Precise interventions targeted to slow or reverse organ aging and improve overall healthspan.
5

Organ Health Outcomes

Repeat testing enables monitoring of change over time and how organs respond to intervention. 

Founding Team

Tony Wyss-Coray

Tony Wyss-Coray

Co-Founder
D.H. Chen Distinguished Professor of Neurology and Neurological Sciences at Stanford
Paul Coletta

Paul Coletta

CEO & Co-Founder
30 years of experience building consumer brands for companies like Disney, HP, Viacom, Urban Remedy
Markus Okumus

Markus Okumus

Co-Founder
30 years founding and building consumer and health companies across the US and Europe — from first idea to exit.

Guided by world-class clinical and scientific expertise

Eric Verdin

Eric Verdin, MD

Scientific Advisor
CEO of the Buck Institute for Research on Aging
Heike Bischoff-Ferrari

Heike Bischoff-Ferrari, MD

Scientific Advisor
Chair, Aging Medicine and Aging Research at the University of Zurich
Michael Doney

Michael Doney, MD

Chief Clinical Advisor
Executive Medical Director, Biograph Clinic
Christin Glorioso

Christin Glorioso, MD, PhD

Medical Advisor
CEO & Co-Founder NeuroAge Therapeutics, Founder Longevity Global

Press & Media

Featured in leading scientific and health publications exploring the future of predictive medicine. 

“Let’s say I were going to start a new medication… you could monitor how that impacts—for better or worse—the age of a particular organ or set of organs.”

Feb 2026

“The hope is that we will do preventive medicine and give people real feedback… it could completely change medicine”

Jan 2026

“The idea that we might be able to change how we age is what’s really exciting about the research”

Nov 2024

“How old is your pancreas?
What about your brain or heart?”

March 2024